Factors associated with disease-specific survival of patients with non-small cell lung cancer

Author:

Souza Mirian Carvalho de1,Cruz Oswaldo Gonçalves2,Vasconcelos Ana Glória Godoi2

Affiliation:

1. Instituto Nacional de Câncer José Alencar Gomes da Silva, Brasil

2. Fundação Oswaldo Cruz, Brazil

Abstract

ABSTRACT Objective: Lung cancer is a global public health problem and is associated with high mortality. Lung cancer could be largely avoided by reducing the prevalence of smoking. The objective of this study was to analyze the effects of social, behavioral, and clinical factors on the survival time of patients with non-small cell lung cancer treated at Cancer Hospital I of the José Alencar Gomes da Silva National Cancer Institute, located in the city of Rio de Janeiro, Brazil, between 2000 and 2003. Methods: This was a retrospective hospital cohort study involving 1,194 patients. The 60-month disease-specific survival probabilities were calculated with the Kaplan-Meier method for three stage groups. The importance of the studied factors was assessed with a hierarchical theoretical model after adjustment by Cox multiple regression. Results: The estimated 60-month specific-disease lethality rate was 86.0%. The 60-month disease-specific survival probability ranged from 25.0% (stages I/II) to 2.5% (stage IV). The performance status, the intention to treat, and the initial treatment modality were the major prognostic factors identified in the study population. Conclusions: In this cohort of patients, the disease-specific survival probabilities were extremely low. We identified no factors that could be modified after the diagnosis in order to improve survival. Primary prevention, such as reducing the prevalence of smoking, is still the best method to reduce the number of people who will suffer the consequences of lung cancer.

Publisher

FapUNIFESP (SciELO)

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide. IARC CancerBase [serial on the Internet];Ferlay J,2013

2. Estimativa 2014: Incidência de câncer no Brasil,2014

3. Pathology of lung cancer;Travis WD;Clin Chest Med,2011

4. Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data;Verdecchia A;Lancet Oncol,2007

5. Clinical features of 5,628 primary lung cancer patients experience at Mayo Clinic from 1997 to 2003;Yang P;Chest,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3